Where Healthcare Meets Growth
Your Partner for Accelerated Business Transformation
Sheridan is a healthcare-focused private equity firm, bringing sector knowledge with a collaborative and strategic approach to building enduring value.
Raised
Platforms
Add-ons
Organic growth achieved vs. industry average
As of December 31, 2025
The Sheridan Foundation is Built Upon
a Lasting Commitment to Our Partners
Sheridan strives to build enduring value by providing growth-oriented solutions across the healthcare landscape.
Engaged, Thesis-Driven Investors
Utilizing a disciplined and focused approach, we seek to partner with founders and management teams in select healthcare subsectors, leveraging our deep connections and extensive resources to help them grow and optimize their operations for the benefit of patients, clients, and shareholders alike.
Helping Build Exceptional
Healthcare Companies
We empower our partners to achieve their goals and meaningfully scale their companies.
Sheridan helped us grow well beyond our expectations, but they were equally thoughtful about knowing when and how to find the right partner for the next phase of our journey.
Scotte Hudsmith CEO & Chairman | Smile Doctors
We could not be more pleased with the outcome of our partnership with Sheridan. Since the very beginning, the Sheridan team invested in our organization and our people to advance our mission of helping hospitals improve patient care through the delivery of our innovative cost-savings solutions.
Dan Geelhoed CEO & Co-Founder | SpendMend
Our company operates within a highly nuanced framework of agency oversight. Sheridan understood this landscape better than any other group and was able to move quickly and decisively to close our deal.
Michael Blaire CEO & Founder | Diamondback Drugs
Sheridan helped us grow well beyond our expectations, but they were equally thoughtful about knowing when and how to find the right partner for the next phase of our journey.
Scotte Hudsmith CEO & Chairman | Smile Doctors
We could not be more pleased with the outcome of our partnership with Sheridan. Since the very beginning, the Sheridan team invested in our organization and our people to advance our mission of helping hospitals improve patient care through the delivery of our innovative cost-savings solutions.
Dan Geelhoed CEO & Co-Founder | SpendMend
Our company operates within a highly nuanced framework of agency oversight. Sheridan understood this landscape better than any other group and was able to move quickly and decisively to close our deal.
Michael Blaire CEO & Founder | Diamondback Drugs
Committed, Capable, and Friendly Partners
Sheridan’s reputation is founded on working collaboratively as we provide access to our extensive healthcare expertise and network. We pride ourselves on the long-term relationships we build with our partners.
Follow Our Progress
Explore the latest news about our investment activity and portfolio companies.
CHICAGO, IL – June 3, 2026 – Sheridan Capital Partners (“Sheridan”) today announced the completion of its investment in Tres Health, Inc. (“Tres” or the “Company”), a national alternative health insurance and technology company. Financial terms of the private transaction were not disclosed.
Mergers & Acquisitions has selected 12 deals for its 19th annual Mid-Market Deals of the Year Awards. These transactions stand out in a year marked by major headwinds for dealmakers, driven in large part by shifting economic policy and geopolitical turbulence.
In the healthcare private equity sector, scale and speed usually dominate the landscape, but at Sheridan Capital Partners, the story is quite different.